Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000730977 | SCV000858747 | pathogenic | not provided | 2017-12-19 | criteria provided, single submitter | clinical testing | |
Neuberg Centre For Genomic Medicine, |
RCV002510582 | SCV002820298 | pathogenic | Ullrich congenital muscular dystrophy 1A | criteria provided, single submitter | clinical testing | The frameshift deletion p.D548Rfs*11 in COL6A1 (NM_001848.3) has been submitted to ClinVar as Pathogenic but no details are available for independent assesment. The variant has not been reported in affected individuals in the literature. The p.D548Rfs*11 variant is novel (not in any individuals) in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. This variant is predicted to cause loss of normal protein function through protein truncation. Loss of function variants have been previously reported to be disease causing. For these reasons, this variant has been classified as Pathogenic |